NT-proBNP measurement is specifically used in patients undergoing which therapy?

Prepare for the Ciulla Clinical Chemistry Test with comprehensive flashcards and detailed multiple-choice questions. Each question includes helpful hints and explanations. Boost your confidence and excel in your test!

Multiple Choice

NT-proBNP measurement is specifically used in patients undergoing which therapy?

Explanation:
NT-proBNP is measured because it reflects the patient’s own heart failure status without being affected by exogenous BNP therapy. Nesiritide is a recombinant BNP given to treat acute decompensated heart failure, and it can cause BNP immunoassays to be falsely elevated since they detect the administered peptide as well as endogenous BNP. NT-proBNP assays, by contrast, do not cross-react with nesiritide, so they provide a clearer picture of the patient’s cardiac status and prognosis when someone is receiving this therapy. This is why NT-proBNP measurement is specifically used in patients undergoing nesiritide therapy.

NT-proBNP is measured because it reflects the patient’s own heart failure status without being affected by exogenous BNP therapy. Nesiritide is a recombinant BNP given to treat acute decompensated heart failure, and it can cause BNP immunoassays to be falsely elevated since they detect the administered peptide as well as endogenous BNP. NT-proBNP assays, by contrast, do not cross-react with nesiritide, so they provide a clearer picture of the patient’s cardiac status and prognosis when someone is receiving this therapy. This is why NT-proBNP measurement is specifically used in patients undergoing nesiritide therapy.

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy